These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9148338)

  • 1. [Inactivated vaccine against hepatitis A: review of the literature and considerations on its use].
    Santos MV; Lopes MH
    Rev Soc Bras Med Trop; 1997; 30(2):145-57. PubMed ID: 9148338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of travelers against Hepatitis A viral infection in developing countries.
    Arya SC
    J Travel Med; 1998 Dec; 5(4):228-9. PubMed ID: 9935325
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing hepatitis A infections in travelers to endemic areas.
    Koff RS
    Am J Trop Med Hyg; 1995 Dec; 53(6):586-90. PubMed ID: 8561258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on the control of hepatitis A by vaccination.
    Kane MA
    Vaccine; 1992; 10 Suppl 1():S93-6. PubMed ID: 1335670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and prevention of hepatitis A in travelers.
    Steffen R; Kane MA; Shapiro CN; Billo N; Schoellhorn KJ; van Damme P
    JAMA; 1994 Sep; 272(11):885-9. PubMed ID: 8078167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of hepatitis A infections: guidelines for use of hepatitis A vaccine and immune globulin. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1996 Dec; 98(6 Pt 1):1207-15. PubMed ID: 8951284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and effectiveness of the new inactivated hepatitis A virus vaccine.
    Furesz J; Scheifele DW; Palkonyay L
    CMAJ; 1995 Feb; 152(3):343-8. PubMed ID: 7828098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A vaccine.
    Nalin DR
    J Occup Environ Med; 1996 Dec; 38(12):1200-1. PubMed ID: 8978510
    [No Abstract]   [Full Text] [Related]  

  • 9. Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use.
    André F; Van Damme P; Safary A; Banatvala J
    Expert Rev Vaccines; 2002 Jun; 1(1):9-23. PubMed ID: 12908508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial.
    Werzberger A; Kuter B; Shouval D; Mensch B; Brown L; Wiens B; Lewis J; Miller W; Sitrin R; Provost P
    J Hepatol; 1993; 18 Suppl 2():S46-50. PubMed ID: 8182273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults.
    Vimolket T; Theamboonlers A; Dumas R; Milcamps B; Forrat R; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):779-85. PubMed ID: 10772564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of reactogenic and immunogenic properties of the children's variant of the domestic vaccine, "Gep-A-in-Vak", against hepatitis A].
    Ikoev VN; Gorbunov MA; Maĭdaniuk AG; Karpovich LG; Kalashnikova TV; Bektimirov TA; Karpova EV; Nemtsov IuV; Muntlieva MA; Kriuk NI
    Vopr Virusol; 1999; 44(3):133-6. PubMed ID: 10392439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaccination against hepatitis A].
    Balli F; Di Biase AR; Viola L
    Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with the inactivated hepatitis A vaccine, Avaxim 80U Pediatric.
    Bravo C; Mege L; Vigne C; Thollot Y
    Expert Rev Vaccines; 2019 Mar; 18(3):209-223. PubMed ID: 30806110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JA; Ruiz Extremera A
    Gastroenterol Hepatol; 1997 Nov; 20(9):467-73. PubMed ID: 9445743
    [No Abstract]   [Full Text] [Related]  

  • 16. Who should receive hepatitis A vaccine? Considerations for the development of an immunization strategy.
    Margolis HS; Shapiro CN
    Vaccine; 1992; 10 Suppl 1():S85-7. PubMed ID: 1335667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of immunization against hepatitis A.
    Lemon SM; Shapiro CN
    Infect Agents Dis; 1994 Feb; 3(1):38-49. PubMed ID: 7952926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, production, and postmarketing surveillance of hepatitis A vaccines in China.
    Cui F; Liang X; Wang F; Zheng H; Hutin YJ; Yang W
    J Epidemiol; 2014; 24(3):169-77. PubMed ID: 24681843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of an inactivated hepatitis A vaccine in pre- and postexposure conditions in marmosets.
    D'Hondt E; Purcell RH; Emerson SU; Wong DC; Shapiro M; Govindarajan S
    J Infect Dis; 1995 Mar; 171 Suppl 1():S40-3. PubMed ID: 7876647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A: epidemiology and prevention.
    Feinstone SM
    Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):300-5. PubMed ID: 8781894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.